Concepedia

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

C J Schmidt, Douglas S. Chapin, J. Cianfrogna, Michael L. Corman, Mihály Hajós, John F. Harms, William E. Hoffman, Lorraine A. Lebel, Sheryl A. McCarthy, Fredrick R. Nelson,

Journal of Pharmacology and Experimental Therapeutics · 2008 · 284 citations · 24 references

DOI

Concepts

References

24

Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative

Dennis S. Charney · American Journal of Psychiatry · 2004 · 1.4K citations

, , +16

Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

Richard S.E. Keefe · Archives of General Psychiatry · 2007 · 1.1K citations

, , +16

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Sandeep T. Patil, Lu Zhang, Ferenc Martényi et al. · Nature Medicine · 2007 · 1K citations

, , +12

Institute of Laboratory Animal Resources.

Thomas L. Wolfle · 1995 · 618 citations

, , +12

Inbred strain differences in prepulse inhibition of the mouse startle response

Richard Paylor, Jacqueline N. Crawley · Psychopharmacology · 1997 · 384 citations · Full text

, , +9